My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

iShares Biotechnology ETF (NQ:IBB)

175.04 +4.32 (+2.53%)

Streaming Delayed Price Updated: 3:43 PM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about iShares Biotechnology ETF

Biotech Boom Ahead? Key Stocks and ETFs to Watch Now

September 23, 2024

The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.

Via MarketBeat

Topics ETFs Economy

Biotech Breakout: Stocks for Your Watchlist

September 12, 2024

The iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150.

Via MarketBeat

Topics ETFs

CPI Data Sparks Rally in Biotech Stocks

July 15, 2024

Following lower-than-expected inflation data on Thursday, The biotech sector broke out above resistance, closing the week up 6%, far outperforming the market.

Via MarketBeat

Topics ETFs Economy

AbbVie Stock: A Perfect Dip for Investors to Buy

July 03, 2024

ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investors

Via MarketBeat

Topics ETFs

Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex

July 02, 2024

The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.

Via MarketBeat

Topics ETFs

Gilead Sciences Stock Surges on HIV Treatment Trial Success

June 21, 2024

Gilead Sciences (NASDAQ: GILD) saw its stock jump nearly 10% yesterday after announcing groundbreaking results from its HIV treatment trial.

Via MarketBeat

Will the Biotech Sector Shift From Lagger to Leader?

May 10, 2024

The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs.

Via MarketBeat

Topics ETFs

Biotech Sector Nears Breakout: Will it Outperform in Q2?

April 03, 2024

The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains

Via MarketBeat

Topics ETFs

Will the Biotech sector sustain its momentum in 2024?

January 04, 2024

The iShares Biotechnology ETF (NASDAQ: IBB) emerged as a standout star, closing the first day of the year with a solid upswing of nearly 4%.

Via MarketBeat

Topics ETFs

MarketBeat Week in Review – 12/4 - 12/8

December 09, 2023

Stocks finished in the green to close the week; investors believe the jobs report will allow the Fed to leave interest rates unchanged when they meet next week

Via MarketBeat

Topics Economy

3 biotech powerhouses poised to thrive amid sector rebound

December 08, 2023

If the newfound support and uptrend in the biotech sector last, as the new year quickly approaches, the biotech sector could shift from lagger to leader.

Via MarketBeat

Topics ETFs

Biotech reversal confirmed: what's ahead for the IBB?

December 08, 2023

The recent reversal and reclaim of the significant $124 support level in the IBB holds importance, indicating a potential shift in momentum.

Via MarketBeat

Topics ETFs

3 Strong Biotech Performers To Watch As Sector Nears Breakout

August 17, 2023

As the IBB ETF nears a potential breakout, watch for strong performers like Regeneron Pharmaceuticals, Vertex, and Exelixis to continue outperforming.

Via MarketBeat

Topics ETFs

Moderna: Declining Performance And Relative Weakness

June 30, 2023

Moderna's value has declined by over 75% from its peak as the world moves on from the COVID-19 pandemic, leading to concerns about its investment appeal.

Via MarketBeat

Topics ETFs

Is the Biotech Industry (IBB) Poised For A Major Breakout?

June 12, 2023

The current consolidation in the IBB signals a potential breakout might be looming as key moving averages have converged within a contracted price range.

Via MarketBeat

Topics ETFs

Tarsus Added to NASDAQ Biotechnology Index

December 16, 2022

From Tarsus Pharmaceuticals, Inc

Via GlobeNewswire

BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients

December 02, 2022

The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption. Smart Beta EFTs...

Via TheNewswire.com

Topics Stocks

BlackRock Announces Product Updates to Two iShares ETFs

April 22, 2021

From BlackRock, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.